PET Diagnostic Molecules Utilizing Multimeric Cyclic RGD Peptide Analogs for Imaging Integrin α_vβ₃ Receptors

Area of Science:

• Radiochemistry and Molecular Imaging
• Oncology and Cancer Diagnostics
• Bioconjugate Chemistry

Background:

• Integrin αvβ3 receptors are crucial for tumor angiogenesis and are overexpressed on cancer cells.
• Multimeric ligands, with multiple pharmacophores on a single backbone, enhance targeting capabilities.
• Cyclic arginine-glycine-aspartic (c(RGD)) peptides are effective ligands for integrin αvβ3.

Purpose of the Study:

• To review recent advancements in multimeric radioligands targeting integrin αvβ3 for PET imaging.
• To analyze the structure-property relationships of these multimeric ligands.
• To discuss their diagnostic and therapeutic potential in cancer.

Main Methods:

• Review of literature on multimeric c(RGD) radioligands for PET imaging.
• Analysis of binding avidity, pharmacodynamics, and imaging properties.
• Inclusion of preclinical and clinical study examples.

Main Results:

• Multimeric c(RGD) ligands demonstrate superior performance over monomeric versions.
• Various PET radionuclides (18F, 64Cu, 68Ga) can be used for radiolabeling.
• Structural modifications influence imaging characteristics and efficacy.

Conclusions:

• Multimeric radioligands targeting integrin αvβ3 are promising for molecular imaging and diagnostics.
• These agents offer enhanced avidity and improved PET imaging properties for cancer detection.
• Further preclinical and clinical investigations are warranted to optimize their use.